News Conference News ESOC 2024 TEMPO-2: Tenecteplase No Help in Mild Stroke With Proven Occlusion Todd Neale May 23, 2024
News Conference News ESOC 2024 More Trial Evidence Supports Tenecteplase for Acute Stroke Thrombolysis Todd Neale May 21, 2024
News Conference News ESOC 2024 INTERACT4: Impact of Prehospital BP-Lowering May Depend on Acute Stroke Type Todd Neale May 20, 2024
News Conference News ESOC 2024 Colchicine Misses in Secondary Stroke Prevention, but Door Not Closed Yet Todd Neale May 16, 2024
News Conference News EuroPCR 2024 NOW PUBLISHED - Latest TAVI vs Surgery Trial Raises Eyebrows in Aortic Stenosis Plus CAD Michael O'Riordan May 14, 2024
Presentation EuroPCR 2024 Impact of valve type and anaesthesia strategy for TAVI – 5-year results of the SOLVE-TAVI trial Presenter: Hans-Josef Feistritzer May 14, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for April 2024 Shelley Wood April 30, 2024
News Daily News Diltiazem and DOAC Interaction Increases Bleeding Risk in AF L.A. McKeown April 18, 2024
News Daily News Lp(a) Linked to Higher ASCVD Risks in Diverse Patient Groups Michael O'Riordan April 17, 2024
News Daily News Tirzepatide Eases Obstructive Sleep Apnea in Patients With Obesity Todd Neale April 17, 2024
News Conference News ACC 2024 Need a Statin for Primary Prevention? There’s an App for That Michael O'Riordan April 10, 2024
News Conference News EHRA 2024 Study Bolsters AF’s Link to Brain Infarcts, Cognitive Impairment Todd Neale April 08, 2024
News Conference News ACC 2024 Faster CAC Progression After Menopause May Warrant Intensified Therapy L.A. McKeown April 04, 2024
News Conference News ACC 2024 Heavy Drinking May Contribute to CHD Risk in Young Women L.A. McKeown April 02, 2024
News Daily News Antihypertensives Linked to Lower Long-term Dementia Risk Caitlin E. Cox April 01, 2024
News Conference News ACC 2024 Icosapent Ethyl Lowers CV Risk Across Lp(a) Range: REDUCE-IT Todd Neale March 27, 2024
News Conference News THT 2024 Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients Michael O'Riordan March 07, 2024